RNA dimerization defect in a Rous sarcoma virus matrix mutant

L J Parent1, T M Cairns, J A Albert

  • 1Department of Medicine, The Pennsylvania State University College of Medicine, M. S. Hershey Medical Center, Hershey, Pennsylvania 17033, USA.

Journal of Virology
|December 10, 1999
PubMed

Insights

A Rous sarcoma virus (RSV) matrix (MA) mutant, Myr1E, shows a replication defect due to impaired genomic RNA dimerization, not myristoylation. Restoring RNA dimerization rescues infectivity, suggesting MA’s role in RNA packaging.

Area of Science:

  • Retroviral assembly and replication
  • Molecular virology
  • Protein-domain interactions

Background:

  • The retrovirus matrix (MA) protein is crucial for membrane targeting during virus assembly.
  • MA mutants in various retroviruses exhibit defects in infectivity despite normal particle release.
  • The function of MA in genomic RNA packaging and dimerization remains incompletely understood.

Purpose of the Study:

  • To investigate the function of the Rous sarcoma virus (RSV) MA protein in viral particle assembly and infectivity.
  • To characterize a novel RSV MA mutant, Myr1E, with an N-terminal Src oncoprotein domain.
  • To determine the role of MA in genomic RNA dimerization and its impact on viral replication.

Main Methods:

  • Construction and characterization of the RSV MA mutant Myr1E.
  • Biochemical analysis of viral particle composition, including Gag cleavage products, Env glycoproteins, and reverse transcriptase activity.
  • Analysis of genomic RNA incorporation, dimerization status, and template activity using Northern blots and reverse transcriptase assays.
  • Infectivity assays in avian cells.

Main Results:

  • The Myr1E mutant, despite normal particle release and Gag processing, is non-infectious.
  • Myristoylation of the N-terminal extension is not the cause of the replication defect.
  • Myr1E particles exhibit defective genomic RNA dimerization, with RNA appearing monomeric.
  • Genomic RNA from Myr1E particles can serve as a template for reverse transcription in vitro but not in vivo after infection.

Conclusions:

  • The replication defect in Myr1E is linked to impaired genomic RNA dimerization, not myristoylation.
  • The study suggests a novel role for the MA protein in facilitating or stabilizing genomic RNA dimerization.
  • Interference with RNA dimerization by the mutant MA protein may explain the observed block in viral replication.

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...